Download presentation
Presentation is loading. Please wait.
Published byAusten Palmer Modified over 9 years ago
1
The Future of Telematics in Pharmaceuticals FEDESA observations Andrew Fleetwood
2
Points to consider Transparency Scalability International aspects Pharmacovigilance Languages Accessibility Feasibility Partnership
3
Transparency Many telematics initiatives are in progress under an overall strategy –industry not familiar with management structure –not all initiatives are understood by industry therefore difficult to constructively comment Proposal: –Open telematics web site to engage industry and encourage comment/ input
4
Scalability –Limited resources in veterinary pharmaceutical industry –Need to deal with “legacy” documents (eg MRLs and generic applications) Proposals: –developments in telematics should encourage use of IT without placing unintentional barriers –open web site to encourage even smallest companies to be involved
5
International dimension Use of telematics being considered in other territories/ arenas (e.g VICH, US CVM) –Particular note: e-compliance (21CFR11), e-submissions, e-CTD/ ICH/VICH Proposals: –track/ consider/ collaborate in developments in other arenas –make full use of VICH process
6
Pharmacovigilance Industry supports the development of a robust EU pharmacovigilance system based on telematics –Looking to this replacing need for 5-yearly renewals Proposal: –industry ready to play its part in supporting development of the system (incl. international dimension)
7
Languages Current systems produce significant hurdles to smaller companies (and larger ones!) Situation will approach melt-down with accession to EU Easy opportunities to make improvements Proposal: –Industry will work with agencies to develop pragmatic and workable solutions
8
Accessibility Current websites are difficult to navigate and not well linked together Technical performance of HEVRA website could be improved Proposal: –co-ordinated plan to update websites and ensure all are appropriately resourced
9
Feasibility Important point to be considered: Economical resources needed should be proportionate to veterinary sector
10
Partnership Involving industry by intellectual partnership produces good results –e.g. EPARs, PIM/x-Dossier initiative, VICH Transparency is the key to partnership and involvement and is FEDESAs overriding goal.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.